Elevation Pharmaceuticals

About:

Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for the COPD patients.

Website: http://www.elevationpharma.com

Top Investors: Canaan Partners, TPG Growth, Novo Ventures, Care Capital, TPG Biotech

Description:

Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives. At Elevation, they have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. They are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders -- employees, investors, partners, and patients.

Total Funding Amount:

$89.4M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)elevationpharma.com

Founders:

Bill Gerhart

Number of Employees:

11-50

Last Funding Date:

2012-01-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai